Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 849 of 6351
-
Immunotherapy combo shows promise in shrinking Hard-to-Treat head and neck tumors
Disease control OngoingNeoadjuvant chemotherapy plus toripalimab in patients with locoregionally advanced nasopharyngeal carcinoma
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Lung cancer vaccine combo shows promise in early trial
Disease control OngoingThis study is researching an investigational drug, called BNT116, in combination with cemiplimab. BNT116 and cemiplimab will each be called a "study drug", and together be called "study drugs". The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New lupus drug shows promise in major trial
Disease control OngoingThe trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug BL-B01D1 targets Hard-to-Treat solid tumors in early trial
Disease control Recruiting nowPhase IIa/IIb clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of BL-B01D1 for injection in patients with multiple solid tumors such as locally advanced or metastatic urinary system tumors.
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New eczema drug shows promise for teens in major trial
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent participants.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Robotic surgery and heated chemo could be a Game-Changer for stomach cancer patients
Disease control Recruiting nowThis phase II clinical trial tests how well robotic cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in treating patients with gastric cancer that has spread to the tissue that lines the wall of the abdominal cavity (peritoneum). Gastric cancer is the third lea…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a vibrating patch restore lost foot sensation?
Symptom relief CompletedThe study will explore the use of a haptic device for sensory substitution in individuals with a movement disorder that has caused loss of plantar sensation. The haptic device consists of two components. The first element is a flexible insole with embedded pressure-sensing elemen…
Sponsor: Shirley Ryan AbilityLab • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can exosome shots outperform minoxidil for baldness?
Disease control CompletedAndrogenetic alopecia (AGA) is a common form of hair loss characterized by progressive hair follicle miniaturization. This prospective randomized comparative study evaluates the efficacy and safety of intradermal exosome injections compared with 5% topical minoxidil in patients w…
Sponsor: Tanta University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Heart valve showdown: which TAVI design saves more lives?
Disease control OngoingOver the last years, several randomized studies comparing transcatheter aortic valve implantation (TAVI) to surgical aortic valve replacement (SAVR) have established TAVI as a treatment option in symptomatic patients with aortic stenosis (AS) (1,2,3). Most transcatheter heart val…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo shows promise for tough lung cancers
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability and objective response rate of SKB264 as combination with therapy in subjects with advanced or metastatic non-small cell lung cancer.
Phase 2 • Sponsor: Klus Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a short course of hepatitis c drugs before kidney transplant prevent infection?
Disease control Recruiting nowThis study is being done to find out the best time to start medication for Hepatitis C Virus (HCV) in HCV-negative recipients of HCV-positive (HCV D+/R-) kidney transplants. Participants will be randomized into one of two groups: Arm 1 - Prophylaxis: This group will start the HC…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
HER2+ breast cancer patients may finally get a treatment holiday
Disease control OngoingThis study is being done to see if anti-HER2 treatment be safely stopped in patients with HER2-positive metastatic breast cancer (MBC) that have had exceptional response to treatment. Exceptional response" is considered as cancer progression being controlled for three years or mo…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug combo aims to stop blood cancer relapse after transplant in kids
Disease control OngoingThe purpose of this study is to examine if it is feasible to administer decitabine and filgrastim after allogenic hematopoietic stem cell transplant (HCT) in children and young adults with myelodysplastic syndrome, acute myeloid leukemia and related myeloid disorders, and if the …
Phase 2 • Sponsor: Franziska Wachter • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New study aims to catch lung cancer earlier in smokers
Diagnosis Recruiting nowObservational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.
Sponsor: AstraZeneca • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
New drug cocktail aims to stop kidney cancer comeback
Disease control Recruiting nowThe study included 298 RCC patients who were at high risk for recurrence after nephrectomy (T2G3-4 or T3-4 or N1). They were randomly divided to receive axitinib plus PD-1 + surgery or surgery alone at a ratio of 1:1, so as to determine the efficacy of the neoadjuvant combination…
Phase 3 • Sponsor: ZHOU FANGJIAN • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Exercise and diet counseling may help cancer patients finish chemo
Disease control Recruiting nowAn anticipated 200 women with newly diagnosed ovarian and endometrial cancer scheduled to receive chemotherapy (adjuvant chemotherapy after surgery or neoadjuvant chemotherapy before surgery) will be recruited from Smilow Cancer Hospital Network at Yale Cancer Center (YCC) and Sy…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could pregnancy exposures shape neurodevelopment? massive study aims to find out
Knowledge-focused Recruiting nowNeurodevelopmental disorders such as attention deficit disorder with or without hyperactivity, autism spectrum disorder, language and social communication disorder, motor coordination disorder, learning disorder (dyslexia, dyscalculia, dysorthography), intellectual development di…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could a CO2-Removal device save lives in severe COPD attacks?
Disease control Stopped earlyThe aim of the study is to determine which standard of care strategy will best benefit very severe Acute Exacerbation (AE) of Chronic Obstructive Pulmonary Disease (COPD), single versus reinforced with ECCO2R and assess the respective efficacy and the safety. Very severe AE of CO…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill may keep endometrial cancer at bay longer
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors versi…
Phase 3 • Sponsor: Karyopharm Therapeutics Inc • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control OngoingThis is a Phase 1, Open-Label, Dose Escalation and Expansion, Multicenter Study of Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects with Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarci…
Phase 1 • Sponsor: Legend Biotech USA Inc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC